High parathormone levels are associated with adverse cardiovascular events in coronary patients with high fibroblast growth factor-23
Event:
ESC Congress 2020
Topic:
Epidemiology, Prognosis, Outcome
Session:
Coronary Artery Disease (Chronic) ePosters
